Symbicort Turbuhaler approved in China asan anti-inflammatory reliever in mild asthma Symbicort Turbuhaler becomes the first dual-combinationtherapy approved in China for mild, moderate and severe ...

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced the approval of the company's Symbicort Turbuhaler in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to ...

Last week, the British drugmaker trumpeted top-line results from a study in which ICS/LABA drug Symbicort met its primary endpoint, beating out formoterol Turbuhaler at cutting down on ...